Lasa Supergenerics Limited, a active public limited company, was established on 11 March 2016 in Khed, Maharashtra, India. Engaging in animal pharmaceuticals & healthcare within the manufacturing sector, it holds CIN: L24233MH2016PLC274202. Registered under ROC Roc Mumbai. it is listed on BSE: 540702 and NSE: LASA. It has an authorized capital of ₹100.33 Cr and a paid-up capital of ₹50.10 Cr.
It upholds a compliant status. In 2023, it reported revenue of ₹131.37 Cr and a net worth of ₹118.29 Cr. Employing 326 professional, Its leadership includes Omkar Herlekar Pravin (Managing Director), Prathmesh Prakash Chalke (Additional Director), Ketan Bhau Songal (Additional Director). Past directors included Sumant Madhusudan Kharasamble, Pravin Shivdas Herlekar, Manali Roop Bhagtani. It holds no open charges and ₹84.64 Cr settled loans. Its latest AGM occurred on 27 September 2024, with the balance sheet filed on 31 March 2024. It is based at Plot No. C-4, C-4/1, Midc Lote Parshuram Industrial Area, Tal -Khe, D,, Khed, Maharashtra, 415722.
L24233MH2016PLC274202
274202
11 March 2016
₹100.33 Cr
₹50.10 Cr
Roc Mumbai
Listed (BSE: 540702, NSE: LASA)
Active
Explore comprehensive insights into Lasa Supergenerics Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Omkar Herlekar Pravin | Managing Director | 11 Mar 2016 | Current |
| Prathmesh Prakash Chalke | Additional Director | 21 May 2025 | Current |
| Ketan Bhau Songal | Additional Director | 04 Aug 2025 | Current |
| Pravin Gadalya Lachake | Additional Director | 04 Aug 2025 | Current |
| Yogesh Hari Ughada | Additional Director | 04 Aug 2025 | Current |
| Rekha Hemant Wakh | Additional Director | 04 Aug 2025 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Whole-Time Director | 16 Jun 2018 | Past |
| Pramod Abcsdd | Director | 02 May 2017 | Past |
| Pramod Abcsdd | Director | 12 Feb 2018 | Past |
| Pramod Abcsdd | Cfo | 25 Apr 2024 | Past |
| Pramod Abcsdd | Additional Director | 15 May 2018 | Past |
| Pramod Abcsdd | Director | 02 May 2017 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Lasa Supergenerics Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 4.24% decrease. The company also saw a substantial fall in profitability, with a 619.57% decrease in profit. The company's net worth observed a substantial decline by a decrease of 20.42%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Lasa Supergenerics had a promoter holding of 53.65% and a public holding of 46.35%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹0
₹846,400,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 26 Apr 2018 | Others | ₹6.03 Cr | Satisfied |
| 31 Mar 2018 | Others | ₹1.82 Cr | Satisfied |
| 28 Nov 2012 | Axis Bank Limited | ₹76.79 Cr | Satisfied |
Explore comprehensive loan charge details -
Lasa Supergenerics has a workforce of 326 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Lasa Supergenerics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Lasa Supergenerics's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Ketan Bhau Songal was appointed as a Additional Director was appointed as a Additional Director on 04 Aug 2025 & has been associated with this company since 3 months 26 days . was recorded as a recent event.
Pravin Gadalya Lachake was appointed as a Additional Director was appointed as a Additional Director on 04 Aug 2025 & has been associated with this company since 3 months 26 days . was recorded as a recent event.
The activity Yogesh Hari Ughada was appointed as a Additional Director was appointed as a Additional Director on 04 Aug 2025 & has been associated with this company since 3 months 26 days . was completed.
Rekha Hemant Wakh was appointed as a Additional Director was appointed as a Additional Director on 04 Aug 2025 & has been associated with this company since 3 months 26 days . was recorded as a recent event.
The activity Prathmesh Prakash Chalke was appointed as a Additional Director was appointed as a Additional Director on 21 May 2025 & has been associated with this company since 6 months 10 days . was completed.
Progress on Lasa Supergenerics Limited last Annual general meeting of members was held on 27 Sep 2024 as per latest MCA records. was documented.
The CIN of Lasa Supergenerics Limited is L24233MH2016PLC274202.
Lasa Supergenerics Limited is headquartered at Plot No. C-4, C-4/1, Midc Lote Parshuram Industrial Area, Tal -Khe, D,, Khed, Maharashtra, 415722.
Lasa Supergenerics Limited was incorporated on 11 March 2016.
The current directors of Lasa Supergenerics Limited are
The primary industry of Lasa Supergenerics Limited is Manufacturing.
Lasa Supergenerics Limited is listed. It is listed on BSE: 540702 and NSE: LASA.
The authorized capital of Lasa Supergenerics Limited is ₹100.33 Cr, and the paid-up capital is ₹50.10 Cr.
The compliance status of Lasa Supergenerics Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX